Related Experiment Videos
Cryptosporidium spp. CP15 and CSL protein-derived synthetic peptides' immunogenicity and in vitro seroneutralisation
Catalina Avendaño1, Mark Jenkins2, Gina Méndez-Callejas3
1Universidad de Ciencias Aplicadas y Ambientales U.D.C.A, Animal Sciences Faculty, Bogotá D.C., Colombia.
Abstract:
Cryptosporidium spp. is a zoonotic intracellular protozoan and a significant cause of diarrhoea in humans and animals worldwide. This parasite can cause high morbidity in immunocompromised people and children in developing countries, livestock being the main reservoir. This study was aimed at performing preliminary tests on Swiss albino weaned mice (ICR) to evaluate the humoral immune response induced against peptides derived from Cryptosporidium parvum CP15 (15 kDa sporozoite surface antigen) and CSL (circumsporozoite-like antigen) proteins. Peptides were identified and characterised using bioinformatics tools and were chemically synthesised. The antibody response was determined and the neutralising effect of antibodies was measured in cell culture. Despite all peptides studied here were capable of stimulating antibody production, neutralising antibodies were detected for just two of the CP15-derived ones. Additional studies aimed at evaluating further the potential of such peptides as vaccine candidates are thus recommended.
Insights
Researchers tested peptides from Cryptosporidium parvum proteins in mice to assess immune responses. Two peptides from CP15 showed potential for developing a Cryptosporidium vaccine.
Area of Science:
- Parasitology
- Immunology
- Vaccine Development
Background:
- Cryptosporidium spp. is a zoonotic protozoan causing global diarrhea in humans and animals.
- Immunocompromised individuals and children are particularly vulnerable, with livestock as a primary reservoir.
- Developing effective vaccines against Cryptosporidium is crucial for public health.
Purpose of the Study:
- To evaluate the humoral immune response against peptides from Cryptosporidium parvum CP15 and CSL proteins.
- To identify potential vaccine candidates by assessing antibody production and neutralization.
- To conduct preliminary tests in Swiss albino mice (ICR).
Main Methods:
- Bioinformatic identification and characterization of peptides from CP15 and CSL proteins.
- Chemical synthesis of identified peptides.
- Assessment of antibody response and neutralizing effects in cell culture using mouse models.
Main Results:
- All synthesized peptides stimulated antibody production in mice.
- Neutralizing antibodies were detected for only two peptides derived from the CP15 antigen.
- The study identified specific CP15 peptides with potential for further vaccine development.
Conclusions:
- Peptides derived from Cryptosporidium parvum CP15 and CSL proteins can elicit an immune response.
- Specific CP15-derived peptides demonstrate potential as vaccine candidates due to their ability to induce neutralizing antibodies.
- Further research is recommended to fully evaluate these peptides for Cryptosporidium vaccine development.